Melanoma study finds mRNA vaccine combined with standard treatment could reduce recurrence

NBC News
NBC News
46.9 هزار بار بازدید - پارسال - In a stage two clinical
In a stage two clinical trial, researchers found that adding an mRNA cancer vaccine to standard treatment reduced the chances for melanoma recurrence or death by 44 percent. NBC News’ Kristen Dahlgren spoke to one of the study’s doctors and a patient for more details.

» Subscribe to NBC News: http://nbcnews.to/SubscribeToNBC
» Watch more NBC video: http://bit.ly/MoreNBCNews

NBC News Digital is a collection of innovative and powerful news brands that deliver compelling, diverse and engaging news stories. NBC News Digital features NBCNews.com, MSNBC.com, TODAY.com, Nightly News, Meet the Press, Dateline, and the existing apps and digital extensions of these respective properties.  We deliver the best in breaking news, live video coverage, original journalism and segments from your favorite NBC News Shows.

Connect with NBC News Online!
NBC News App: https://smart.link/5d0cd9df61b80
Breaking News Alerts: https://link.nbcnews.com/join/5cj/bre...
Visit NBCNews.Com: http://nbcnews.to/ReadNBC
Find NBC News on Facebook: http://nbcnews.to/LikeNBC
Follow NBC News on Twitter: http://nbcnews.to/FollowNBC
Get more of NBC News delivered to your inbox: nbcnews.com/newsletters

#NBCNews #Cancer #Vacciner
پارسال در تاریخ 1402/01/28 منتشر شده است.
46,994 بـار بازدید شده
... بیشتر